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Summary. Background: G protein-coupled receptors (GP-
CRs) are a major family of signaling molecules, central to
the regulation of inflammatory responses. Their activation
upon agonist binding is attenuated by GPCR kinases
(GRKs), which desensitize the receptors through phos-
phorylation. G protein-coupled receptor kinase 2(GRK2)
down-regulation in leukocytes has been closely linked to
the progression of chronic inflammatory disorders such as
rheumatoid arthritis and multiple sclerosis. Because leuko-
cytes must interact with the endothelium to infiltrate
inflamed tissues, we hypothesized that GRK2 down-regu-
lation in endothelial cells would also be pro-inflammatory.
Objectives: To determine whether GRK2 down-regulation
in endothelial cells is pro-inflammatory. Methods: siRNA-
mediated ablation of GRK2 in human umbilical vein endo-
thelial cells (HUVECs) was used in analyses of the role of
this kinase. Microscopic and biochemical analyses of Wei-
bel-Palade body (WPB) formation and functioning, live
cell imaging of calcium concentrations and video analyses
of adhesion of monocyte-like THP-1 cells provide clear evi-
dence of GRK2 function in histamine activation of endo-
thelial cells. Results: G protein-coupled receptor kinase 2
depletion in HUVECs increases WPB exocytosis and P-se-
lectin-dependent adhesion of THP-1 cells to the endothelial
surface upon histamine stimulation, relative to controls.
Further, live imaging of intracellular calcium concentra-
tions reveals amplified histamine receptor signaling in
GRK2-depleted cells, suggesting GRK2 moderates WPB
exocytosis through receptor desensitization. Conclusions:
G protein-coupled receptor kinase 2 deficiency in endothe-
lial cells results in increased pro-inflammatory signaling
and enhanced leukocyte recruitment to activated endothe-
lial cells. The ability of GRK2 to modulate initiation of
inflammatory responses in endothelial cells as well as leu-
kocytes now places GRK2 at the apex of control of this
finely balanced process.
Keywords: G protein coupled receptor kinase 2; human
umbilical vein endothelial cells; P-selectin; von Willebrand
factor; Weibel-Palade bodies.
Introduction
To initiate an inflammatory response, both leukocytes and
endothelial cells need to be activated by hormones and pro-
inflammatory cytokines. The subsequent cell-surface
expression of adhesion molecules in both cell types results
in the rolling of leukocytes along the endothelial surface,
before eventual firm adhesion and extravasation [1].
Many signaling pathways involved in both endothelial
and leukocyte activation are initiated by stimulating G
protein-coupled receptors (GPCRs) [2]. GPCR signal
transduction is attenuated by GPCR kinase (GRK)-medi-
ated phosphorylation of agonist-bound receptor. This
promotes b-arrestin binding, which uncouples the recep-
tor from its G proteins and mediates receptor internaliza-
tion and recycling [3,4]. Disruption of this machinery
alters the strength and/or duration of physiological
responses to GPCR ligands [5]. Of seven GRK subfami-
lies, the ubiquitously expressed GRK2 has been most clo-
sely linked to inflammatory [2,6] and cardiovascular
function [6,7].
GRK2 protein levels are higher in leukocytes than
other tissues [8] and its cytokine-induced down-regulation
[9–11] is associated with chronic inflammatory disorders
such as multiple sclerosis (MS) [12] and rheumatoid
arthritis (RA) [9,13], as well as inflammatory pain [14].
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The pathologies of both MS and RA are characterized by
increased leukocyte infiltration of diseased tissues, proba-
bly caused, at least in part, by impaired GRK2-mediated
attenuation of chemokine signaling. For example,
GRK2+/ murine T cells show significantly heightened
migratory responses towards CCL4. This is concurrent
with enhanced calcium signaling and PKB phosphoryla-
tion, indicative of impaired CCR5 desensitization [15].
Moreover, loss of GRK2 in the endothelium can enhance
cytokine expression, increasing the incidence of macro-
phage extravasation in endothelial-GRK2/ mice [16].
Endothelial activation is mediated by pro-inflamma-
tory and procoagulant factors, delivered to the endothe-
lial cell surface by exocytosing Weibel-Palade bodies
(WPBs). These specialized secretory organelles store the
multimeric glycoprotein von Willebrand factor (VWF)
[17] and are formed at the trans-Golgi network [18–20],
with the help of an AP-1/clathrin coat [21]. Upon injury
or infection, mature organelles, previously anchored to
cortical actin [22], fuse with the plasma membrane and
release VWF to initiate hemostasis [23,24]. Other WPB
cargo such as the leukocyte receptor P-selectin, its co-
factor CD63 [25] and pro-inflammatory cytokines are
also delivered to the cell surface or released into the cir-
culation. WPBs are thus central to endothelial regulation
of inflammation.
As GRK2-deficiency in leukocytes has been closely
linked to inflammatory disorders, we determined whether
it also affects the pro-inflammatory behaviour of endothe-
lial cells.
Materials and methods
Cell culture and transfection
Human umbilical vein endothelial cells (HUVECs, TCS
Cellworks, Buckingham, UK) and THP-1 cells (a gift
from Dr Patric Turowski) were cultured as previously
described [26]. Two-round nucleofections (Nucleofector
II, programme U-001, Amaxa Biosystems, Gaithersbrg,
MD, USA) with 200 pmol siRNA and 106 HUVECs
(passage 3) were performed 48 h apart for assay 48 h
later. GRK2 siRNA sequence 1: 5′-UG-
UCCAGUAACUUGAUUCC-3′ (Sigma, St Louis, WA,
USA), sequence 2: 5′-GCUCGCAUCCCUUCUCGAA
UU-3′. Mock transfections were performed using firefly
luciferase siRNA [27]: 5′-CGUACGCGGAAUACUU
CG-3′. For ssHRP [28] expression, 7 lg construct was
included in the second reaction.
Antibodies
Antibodies used were: rabbit polyclonal anti-human VWF
antibody and its HRP-conjugated form (DAKO, Cam-
bridgeshire, UK); sheep polyclonal anti-TGN46 (Abcam,
Cambridge, UK); anti-P-selectin (R&D Systems, Minnea-
polis, MN, USA); rabbit polyclonal anti-GRK2; mouse
monoclonal anti-b-actin (Santa Cruz Biotechnology,
Middlesex, UK); mouse monoclonal anti-MyRIP (a gift
from Professor Seabra, Imperial College London); and
Alexafluor-conjugated (Invitrogen, Paisley, UK) and
HRP-conjugated (Jackson Immunoresearch, Suffolk, UK)
secondary antibodies.
Immunofluorescence and WPB quantification
Transfected HUVECs were fixed and stained as described
previously [21]. Images were taken using a Leica TCS
SPE scanning confocal microscope, a 639 (NA1.3) or
409 (NA1.15) oil immersion lens (NA 1.15) and LAS-AF
Software (Leica, Buckinghamshire, UK). Acquisition set-
tings were: 0.5 lm z-stack step size, 1024 9 1024 pixel
resolution, 3–4 frame average and 19 zoom. For quantifi-
cation, the LAS-AF mark-and-find feature and a motor-
ized stage were used to generate 15–25 random fields of
view (FoV, 300–400 cells) per treatment condition in each
replicate experiment. WPBs were quantified using Image
J; background subtraction was performed on the VWF
channel using a rolling ball algorithm (radius 2 pixels)
and a manual threshold applied. Segmented objects over
0.1 lm2 were counted and measured for Feret’s diameter
(defined as the longest diameter across a WPB in 2D pro-
jection) using Image J.
Secretion assays
VWF secretion assays have been described previously
[21]. Briefly, cells were rinsed and incubated in release
medium for 30 min, then release medium plus
100 ng mL1 phorbol 12-myristate 13-acetate (PMA,
Sigma-Aldrich, St Louis, MO, USA) or 10 lM histamine
for 45 or 30 min, respectively. Medium was collected to
sample VWF release and intracellular VWF determined
from cell lysates. Secreted VWF is presented as a percent-
age of the total VWF (media plus lysates). All results are
normalized to total lysate protein content, as determined
by bicinchoninic assay (Pierce, Rockford, IL, USA).
Total VWF measurements were used to compare VWF
protein expression in mock and GRK2-depleted cells. To
measure unregulated secretion over longer periods, cells
were rinsed and incubated in serum-free release medium
for 4 h, or in optiMEM reduced serum medium (GIBCO,
Paisley, UK) for 7 h.
ssHRP secretion assays
Eight hours post-transfection, cells were rinsed and incu-
bated in phenol red-free HUVEC growth medium (Sigma);
17 h later, medium was collected and cells lysed in 50 mM
Tris/Cl pH2 on ice. Samples were processed and analyzed
as described previously [29]. Secretion is presented as a pro-
portion of total ssHRP (media plus lysates).
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Western blotting
Cell lysates were collected in RIPA buffer (50 mM Tris-
HCl pH 7.5, 300 mM NaCl, 1% deoxcholate, 2% Triton-
X100, 0.1% SDS). Proteins were separated by SDS-
PAGE on 8% acrylamide gels prior to transfer onto a
protran nitrocellulose transfer membrane. Separation of
pro- and mature VWF was performed on precast Novex
(Life Technologies, Paisley, UK) 6% Tris-Glycine
1.5 mm gels. Blots were probed with primary and HRP-
conjugated secondary antibodies (above). Band quantifi-
cation was performed using a Molecular Imager GS-800
densitometer and Quantity One Software (version 4.6.3,
BioRad, Hertfordshire, UK), normalizing against a b-
actin loading control.
VWF multimer analysis
Samples were concentrated using Vivaspin500 centrifugal
filter units (Sartorius, Goettingen, Germany) and run on
SDS-agarose gels as described previously [29]. Multimer
patterns were analyzed using the Image J plot profile
function to measure intensity changes down each lane,
normalized against total signal.
Quantitative PCR
RNA extraction, cDNA preparation and PCR were per-
formed as described previously [22], quantifying normal-
ized expression (using actin) by the DDCT method [30].
Single product amplification was verified by melting curve
analysis and gel electrophoresis. Primers used were:
GRK2 forward: 5′-GGACAGTGATCAGGAGCTCTA-
3′; reverse: 5′-AAGGACTGCATCATGCATGGC3-’;
VWF forward: 5′-GCCATCATGCATGAGGTCAGA-3′;
reverse: 5′-GGCTCCGTTCTCATCACAGAT-3′; actin
forward: 5′-TGGTGGTGAAGCTGTAGCC-3′; reverse:
5′-GCGAGAAGATGACCCAGAT-3′; HRH1 forward:
5′-GGGCCGTCCTCTCTGCCTCTT-3′; reverse: 5′-
GCCGAGGCTCGGGTCTTGGT-3′.
Calcium imaging
29 Fluo-4 calcium indicator, containing 25 lm probene-
cid, was prepared in serum-free release medium as per man-
ufacturer’s instructions (Fluo-4 DirectTM Calcium Assay
Kit, Molecular Probes, Life Technologies, Paisley, UK).
Nucleofected cells seeded onto 1.45-mm glass-bottom
imaging dishes (PAA) were rinsed and loaded with 19
Fluo-4 for 30 min at 37 °C/5% CO2 prior to imaging.
Movies were acquired using an UltraVIEW VoX spinning
disc system (PerkinElmer, Waltham, MA, USA) mounted
on an inverted microscope (TiE; Nikon, Surrey, UK) with
an EM charge-coupled device camera (512 9 512 pixels;
C9100-13; Hamamatsu Photonics, Hertfordshire, UK) and
488- and 561-nm solid-state lasers. Cells were visualized
using a 1009 oil immersion lens (NA 1.4), inside a 37 °C
heat-controlled chamber. Z-stacks of 0.5-lm spacing were
acquired using a piezo stage (NanoScanZ; Prior Scientific,
Cambridgeshire, UK) every 10 s for 10 min. At time-points
60, 300 and 480 s, 10 mM histamine, 200 lm A21387 iono-
phore and 50 mM EGTA were added, respectively, to stim-
ulate cells and provide a maximal (fmax) and minimal
fluorescent signal. To determine changes in intracellular
calcium levels, a 40 9 40 pixel ROI was drawn juxtanucle-
ar in the cytosol for each cell and the mean fluo-4 intensity
measured at every time-frame using Velocity software (Per-
kinElmer). Measurements were normalized against fmax to
eliminate inconsistencies in indicator loading. To align
curves for comparison, Fluo-4 intensity at time-point 60 s
was subtracted from all values.
THP-1 flow assays
Nucleofected HUVECs were seeded onto gelatin-coated l-
slides VI0.4 (ibidi, Munich, Germany). Slides were mounted
on the microscope stage of an Axiovert 100 (Carl Zeiss,
Welwyn Garden City, UK), maintained at 37 °C, and con-
nected to a syringe pump system (Harvard Aparatus, Holl-
iston, MA, USA) to draw fluid through the chamber with a
wall shear stress of 0.07 Pa (0.7 dyne/cm2). Cells were
rinsed with perfusion medium (HBSS containing Ca+2 and
Mg+2 and 0.2% BSA) under flow, then 106
THP1 cells mL1 were perfused across the endothelial sur-
face for 3 min to image steady-state rolling. Next, a 10-min
stimulation of HUVECs, using perfusion medium + 10 lM
histamine, was followed by a second THP-1 cell perfusion
in the absence of secretagogue. The latter was recorded for
5 min to observe monocyte rolling. Movies were taken at
109 objective with a FoV of 784 9 576 pixels
(559.78 9 411.26 lm) using a QIMAGING Scientific
(QIMAGING Scientific, Surrey, Canada) CMOS Rolera
bolt camera, acquiring at a rate of 24 frames/second, and
Micro-Manager 1.4.13 software. To quantify firmly
adhered monocytes on the endothelial surface, random
snapshots were taken in the absence of flow at the end of
the movie. In antibody blocking experiments, HUVECs
were incubated with 15 lg mL1 sheep polyclonal anti-
human P-selectin (R&D Systems, Minneapolis, MN, USA)
or IgG from sheep serum (Sigma-Aldrich) at 37 °C for
30 min prior to experimentation. Antibody was present for
the remainder of the experiment.
Results
Loss of GRK2 reduces WPB numbers
To investigate a potential role for GRK2 in modulating
endothelial behaviour, we examined whether GRK2-
depleted HUVECs produce normal WPBs, a key determi-
nant of endothelial inflammatory function. GRK2 deple-
tion was, on average, 85% (siRNA1, n = 6) or 94%
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Fig. 1. G protein-coupled receptor kinase 2 (GRK2) KD reduces WPB number without affecting biogenesis. (A–C) HUVECs were transfected
with one of two siRNA sequences targeting GRK2, or with luciferase siRNA for mock treatments. (A) Representative western blot. GRK2
depletion was 85% (49–98%, n = 5) for siRNA sequence 1 and 94% (79–99%, n = 7) for siRNA sequence 2 as determined by SDS-PAGE and
quantified by densitometry. GRK2 levels were normalized to b-actin protein expression. (B) Cells were fixed and stained for VWF (green) and
DAPI (blue) and imaged at 639 objective (20–25 fields of view per condition, 450–650 cells) as confocal stacks ready for quantification. Pre-
sented images are maximum intensity projections. Scale bar 20 lm. (C) Quantification of experiments represented in B. WPB number per cell
is reduced by 34% (n = 4, P = 0.024) and 28% (n = 4, P = 0.021) following GRK2 KD using siRNA (i) sequence 1 and (ii) sequence 2, respec-
tively. Data are normalized against the maximum mock value for each experiment. Error bars represent SEM. Statistics were performed using
a Student’s t-test. (iii) Distribution of WPB Feret’s diameter, represented as a cumulative frequency chart of the percentage of total organelles
found in 0.5 lm bins. (D) HUVECs transfected with luciferase (mock) or GRK2 (sequence 2) targeting siRNA were fixed and stained for P se-
lectin (red), VWF (magenta) and MyRIP (green). Scale bar 20 lm.
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(siRNA2, n = 7) effective using two different siRNA
sequences (Fig. 1A). Transfected cells were thus processed
for image analysis. We observed a 34% (siRNA1, 29–
49%, n = 4) and 28% (siRNA2, 19–36%, n = 4) reduc-
tion in WPB numbers upon GRK2 depletion, without
any consistent change in organelle length (Fig. 1C).
To assess whether other WPB characteristics were
altered, recruitment of P-selectin and MyRIP to organ-
elles was also analyzed by immunofluorescence. P-selectin
is an integral membrane protein incorporated into WPBs
at the trans-Golgi network (TGN) [31], whereas the
Rab27A-MyRIP-MyoVA complex is recruited later and
predominantly found on mature organelles [32]. Incorpo-
ration of these proteins into WPBs is therefore indicative
of successful progression through two independent stages
of biogenesis. Both proteins were found to localize
correctly in GRK2-depleted cells, indicating that cargo
selection and maturation is unaffected (Fig. 1D). Further-
more, in both cell populations, 52% of cells showed P-se-
lectin recruitment to WPBs, suggesting it is targeted
equally efficiently (data not shown).
Disruption of WPB biogenesis can result in the loss of
higher molecular weight (HMW) forms of VWF [21]. We
therefore determined the multimeric state of intracellular
VWF as an additional descriptor of organelle structure.
VWF multimerisation was slightly reduced in GRK2-
depleted cells, suggesting either VWF maturation is
reduced or mature protein is being lost from the cell (see
Fig. 2A).
Reduction in WPB numbers is not due to reduced VWF
expression
VWF drives the formation of WPBs [33]. Deficiencies in
VWF expression can therefore reduce WPB numbers, as
seen in von Willebrand disease [34]. To determine if this
is causative of fewer organelles here, VWF protein levels
in control and GRK2 knock-down (KD) cells were quan-
HMW
Lysates
Mock
Mock
Mock2
1.8
1.8
1.6
1.4
1.4
1.2
1.2
1
1
0.8
0.8
0.6 0.6
0.4 0.4
0.2 0.2
0 0
GRK2 KD
GRK2 KD
ProVWF
VWF
GRK2
Actin
GRK2 KD
Mock
Mock
20 µm 20 µm
GRK2 KD
GRK2 KD 1
GRK2 KD1
To
ta
l V
W
F 
pr
ot
ei
n 
(a.
u.)
To
ta
l V
W
F 
m
R
N
A 
(a.
u.)
GRK2 KD2 GRK2 KD1 GRK2 KD2
LMW
A B
D E
C
Fig. 2. von Willebrand factor (VWF) synthesis and processing is normal in GRK2 KD cells. (A) Control and GRK2-depleted cell lysates were
collected in serum-free medium and analyzed on 1.4% SDS-agarose gels under non-reducing conditions to separate VWF multimers. Represen-
tative immunoblot of VWF; multimerisation decreases from top to bottom. (B) VWF content in control and GRK2-depleted cell lysates was
assayed by ELISA and normalized to total protein content as determined by BCA assay. To aid comparison between experiments, data were
then normalized intra-experimentally to the maximal mock reading. Error bars represent SEM. There is no consistent change in VWF protein
levels in GRK2 KD cells (n = 5). (C) Relative VWF mRNA expression in transfected cells was quantified by RT-qPCR. A consistent trend
towards an increase in VWF expression of 24% (14–35%, P = 0.08) with siRNA sequence 1 and 31% (16–57%, P = 0.13) with sequence 2 is
seen in GRK2 KD cells (n = 3). Statistics were performed using a Student’s t-test. (D) Representative immunoblot. Mock and GRK2 KD cells
were lysed in RIPA buffer and run on a 6% Tris-glycine gel to separate proVWF and VWF. Following transfer, the blot was cut and probed
for VWF, GRK2 and b-actin. (E) Mock and GRK2 KD (siRNA sequence 2) cells were fixed and stained for TGN46 to label the TGN and
imaged as confocal stacks at 409 objective. Images presented are representative regions of interest shown as maximum projections. Scale bars
20 lm.
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tified by both ELISA and western blot and found to be
comparable (Fig. 2). VWF transcript, however, was
consistently, although statistically insignificantly,
increased by 24% and 31% (siRNA1 and 2 respectively)
in GRK2-depleted cells (Fig. 2C). Loss of GRK2 thus
does not reduce WPB numbers by reducing VWF expres-
sion.
VWF progression through the early secretory pathway is
unaffected by GRK2 depletion
We next investigated whether WPB formation is GRK2
dependent. If WPB biogenesis is slowed, VWF is likely to
accumulate in pre-Golgi compartments of the secretory
pathway, as observed following expression of VWD-caus-
ing VWF variants [35]. As VWF passage through the
TGN is marked by the furin-mediated cleavage of its pro-
peptide [36], VWF progression through the Golgi can be
determined by the ratio of pro-VWF to VWF. As shown
in Fig. 2(D), this ratio was unaffected by GRK2 deple-
tion, as was the gross morphology of the TGN (Fig. 2E).
GRK2 therefore does not influence WPB numbers by reg-
ulating VWF trafficking through the early secretory path-
way.
GRK2-deficient HUVECs secrete more VWF in the absence
of secretagogue than control cells
If VWF expression and WPB formation are normal in
GRK2-depleted cells, reductions in organelle number are
likely to be the result of increased WPB exocytosis or
constitutive VWF secretion. Steady-state VWF release
was therefore examined by ELISA. When incubated in
reduced-serum medium in the absence of added secreta-
gogue, GRK2-depleted cells released almost 60% more
VWF than controls (Fig. 3Ai). Furthermore, a consistent
(but statistically insignificant) 33% increase in unregu-
lated secretion in the total absence of serum, and hence
stimulus, was also seen in KD cells (Fig. 3Aii). GRK2-
depleted cells thus possess fewer WPBs because they
release more VWF under resting conditions. To determine
whether constitutive secretion is up-regulated in GRK2-
deficient cells, the secretion of ssHRP [28], a marker for
this pathway, was monitored and found to be unchanged.
GRK2 depletion therefore specifically affects VWF
release (Fig. 3B).
A GRK2-depleted endothelium is hyper-responsive to
histamine stimulation
The observed change in VWF release, coupled to the
known role of GRK2 in desensitization, suggested that
WPB loss might result from enhanced sensitivity to
GPCR signaling. To determine whether GRK2 depletion
affects endothelial activation, we challenged cells with his-
tamine, a GPCR agonist [37] and pro-inflammatory stim-
ulant [38] of WPB exocytosis. GRK2 KD cells released
78% (45–179%, n = 6) more VWF than controls during a
30-min incubation with 10 lM histamine, consistent with
increased sensitivity (Fig. 4A). There was no difference in
the multimeric state of the VWF released by GRK2-defi-
cient HUVECs, indicating that similar organelles are
secreted in both cell populations (Fig. 4Aii).
We also performed a secretion assay in the presence of
PMA, a membrane permeant DAG analogue, which
stimulates WPB exocytosis by raising both intracellular
calcium and cAMP levels, independent of cell surface
receptors. Importantly, there was no difference in regu-
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Fig. 3. Unregulated secretion is increased in GRK2 KD cells. (A) Mock and GRK2 KD (siRNA sequence 2) cells were rinsed and incubated
with (i) reduced-serum medium (optiMEM) for 7 h or (ii) serum-free medium for 4 h. Media and cell lysates were then collected and assayed
for VWF content by ELISA, before normalizing to lysate total protein content as determined by BCA assay. The percentage of total VWF
(medium plus lysates) released over 1 h was calculated and is presented here to allow comparison between the two conditions. Error bars repre-
sent SEM. Statistics were performed using Student’s t-test. (Ai) A 59% increase in VWF release is seen in GRK2 KD cells assayed in Opti-
MEM (n = 3, P = 0.01). (Aii) In the absence of serum, a 33% increase in VWF secretion is seen (n = 4, P = 0.3). (B) HUVECs were
transfected with luciferase- or GRK2-targeting siRNA plus ssHRP cDNA. Secreted ssHRP was collected over 17 h in phenol red-free medium
before lysing cells in Tris-Cl pH2. The ssHRP content of media and lysates was determined by kinetic ELISA. Secreted ssHRP is expressed as
a percentage of total ssHRP present in cells at the beginning of the assay (medium plus lysates) and is 84% under both conditions (82–88%,
n = 3). Error bars represent SEM.
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lated secretion between control and KD cells in
this instance, suggesting that the organelles of siRNA-
treated cells are not generally secretion super-competent
(Fig. 4B).
To confirm that the enhanced histamine-stimulated
secretion observed in GRK2-depleted cells was due to
impaired GPCR desensitization, we next investigated the
amplitude of downstream signaling events. Intracellular
calcium concentrations before and during histamine stim-
ulation were monitored by live-imaging cells loaded with
Fluo-4 indicator. As shown in Fig. 5, Ca2+ influx in
response to histamine was augmented in GRK2-depleted
cells relative to controls. This was not due to general
changes in receptor abundance, as HRH1 mRNA, the
only histamine receptor expressed in HUVECs [39], was
equivalent in GRK2 KD and control cells (Fig. 5B).
Endothelial GRK2 is anti-inflammatory
To establish the functional relevance of these changes, we
assayed monocyte-like THP-1 cell adhesion to HUVEC
monolayers. Control and GRK2-depleted HUVECs were
stimulated with histamine before being perfused with 106
THP-1 cells mL1 under flow. The number of firmly
adherent cells after 5 min was found to be increased
almost 3-fold in GRK2-depleted cells (Fig. 6B). This
increase was dependent on P-selectin, because, in the pres-
ence of 15 lg mL1 function-blocking P-selectin anti-
body, THP-1 adhesion was reduced to control levels in
GRK2 KD cells (Fig. 6B). There was no significant dif-
ference in adhesion between control and GRK2-depleted
cells in the absence of secretagogue (Fig. 6B).
To verify that these observations result from increased
WPB exocytosis, and not changes in P-selectin expression,
P-selectin protein levels in mock and KD cell lysates were
examined by SDS-PAGE and found to be comparable
(Fig. 6C). Furthermore, P-selectin targeting to WPBs was
not affected by loss of GRK2 (Fig. 1D). Increased THP-1
cell adhesion to GRK2-depleted HUVECs therefore
results from increased delivery of P-selectin to the plasma
membrane upon stimulation.
Discussion
Extravasation of circulating leukocytes and their subse-
quent migration into afflicted tissue during inflammation
must be tightly regulated, because excessive recruitment
results in inflammatory disease. Leukocyte GRK2 activity
is known to limit leukocyte migration along chemotactic
gradients and thus prevent aberrant tissue infiltration
[9,12,13,15,40]. Here we show for the first time that
GRK2 also regulates endothelial activation and leukocyte
recruitment in vitro. Together these activities have the
potential to limit both early and late events in the initia-
tion of inflammation and thus prevent the harmful accu-
mulation of leukocytes inside the body.
A key pro-inflammatory stimulant of endothelial cells
is histamine [38], which triggers calcium-mediated WPB
exocytosis by binding to HRH1 [39,41], a GPCR phos-
phorylated by GRK2 [37]. Consistent with a failure in
HRH1 desensitization, we report that histamine-invoked
calcium influx is amplified in GRK2-deficient HUVECs,
as is subsequent VWF release. Similar effects of GRK2
depletion on calcium signaling have been reported upon
CCR5 stimulation in activated T cells, suggesting a gen-
eral mechanism for regulation of inflammatory signal
transduction [15]. In addition to GRK2, HUVECs have
been reported to express GRK5 and 6 [42]. To the best
of our knowledge, there is no reported interaction
between these kinases and HRH1 that may complicate
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interpretation of the results presented. GRK5 and 6 do,
however, desensitize other receptors that are capable of
stimulating WPB exocytosis, such as PAR-1 [42], and
thus may contribute to the regulation of other hemostat-
ic and inflammatory pathways in a similar manner to
GRK2.
Histamine signaling through HRH1 has previously
been shown to induce P-selectin-mediated leukocyte roll-
ing in post-capillary venules [39,43]. Consistent with this,
we see a 3-fold increase in the number of THP-1 cells
adhering to GRK2-depleted HUVECs following enhanced
receptor activation. These leukocyte-endothelial interac-
tions rely on the regulated translocation of adhesion mol-
ecules and receptors to the cell surface. In the case of
endothelial P-selectin, this is achieved through WPB exo-
cytosis. The importance of P-selectin in mediating tether-
ing between endothelial cells and leukocytes is well
established [44]. In P-selectin-deficient mice, both initial
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rolling, as seen by intra-vital microscopy, and subsequent
neutrophil recruitment to inflamed sites are severely
impaired [45]. Similarly, antibodies against P-selectin
glycoprotein ligand-1 (PSGL-1), the leukocyte counter-
receptor for P-selectin, block rolling of human polymor-
phonuclear cells in rat mesenteric venules [46]. Here we
indicate that the converse is also true; enhanced delivery
of P-selectin to the endothelial surface can promote exces-
sive accumulation of adherent leukocytes.
Consistent with our data, increased cell-surface P-selec-
tin has been shown to correlate with the development of
inflammatory infiltrates in a number of pathologies. In
murine atherosclerotic lesions, histochemical staining of
endothelial P-selectin is strongest at sites of active macro-
phage infiltration [47]. Moreover, VEGF-induced P-selec-
tin up-regulation leads to psoriasis and contact dermatitis
[48], whereas enhanced surface translocation of P-selectin
in pancreatic capillaries, through WPB exocytosis, vastly
contributes to the progression of severe acute necrotizing
pancreatitis [49]. Endothelial P-selectin expression is also
increased in the inflamed synovial tissue of patients with
rheumatoid arthritis [50], where it promotes monocyte-
microvasculature interactions [51]. Paradoxically, loss of
P-selectin is reported to enhance progression of murine
collagen-induced arthritis [52]; the contribution of adhe-
sion molecules to inflammatory responses is therefore
complex. It is unknown whether endothelial GRK2 is
down-regulated in any of these pathologies; however, it is
tempting to speculate that augmentation of endothelial
activation would serve to exacerbate the already
enhanced chemotactic responses of GRK2-deficient leu-
kocytes.
Recently, endothelial-targeted deletion of GRK2 in
mice revealed that, even in the absence of pro-inflamma-
tory mediators, loss of GRK2 in the endothelium triggers
macrophage infiltration [16]. This is attributed to up-reg-
ulation of cytokine expression in response to reactive
oxygen species (ROS), generated by GRK2-depleted
mitochondria. Here we provide a more direct mechanism
by which loss of GRK2 could promote leukocyte adher-
ence to the endothelial wall, and thus extravasation,
through impaired inflammatory receptor desensitization
and enhanced WPB exocytosis. This could occur down-
stream of the systemic cytokine signaling induced by loss
of GRK2 itself, or upon development of inflammatory
disease. How these mice respond to infection or induc-
tion of chronic inflammatory conditions remains to be
tested.
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The storage of both P-selectin and VWF in the same
secretory compartment ensures coordinated delivery of
both proteins to the cell surface, implying they function in
the same processes. Although THP-1 accumulation in
GRK2-depleted cells was P-selectin dependent here, the
increased secretion of VWF from these cells may also
affect inflammation. VWF is itself capable of interacting
with PSGL-1 via its A1 domain, an interaction enhanced
by the presence of b2-integrins [53]. The involvement of
the latter, plus observations of reduced rolling in P-selec-
tin-deficient mice [45], suggests these interactions are more
important in the latter stages of leukocyte recruitment and
adhesion. The combined action of increased P-selectin and
VWF secretion is therefore consistent with the strong
impact of GRK2 depletion on firm adhesion, described
here, as opposed to just rolling. We speculate that in vivo,
the inflammatory effects of increased VWF secretion could
be yet further enhanced through the recruitment of large
numbers of activated platelets, which themselves induce P-
selectin-dependent leukocyte rolling and WPB exocytosis
[54]. Platelets also up-regulate expression of additional
adhesion molecules, such as E-selectin and VCAM-1 [55],
and further enhance leukocyte activation [56].
Delivery of a bolus of adhesion molecules to the endo-
thelial membrane requires the formation of functionally
competent secretory organelles. We find that GRK2
depletion does not significantly affect WPB morphology
or cargo recruitment, including incorporation of P-selec-
tin. Interestingly, loss of GRK2 does, however, result in a
30% reduction in WPB numbers. This may be explained
by the observed increase in unregulated VWF secretion,
which is most likely attributable to basal exocytosis of
WPBs as described by Giblin et al. [57]. Interestingly, this
increase in VWF release is not accompanied by a change
in steady-state levels of VWF protein, although as WPBs
contain approximately 50% of all intracellular VWF [58],
a 30% fall in organelle number is only expected to result
in a relatively small reduction in total protein. As the
relationship between levels of VWF and numbers of
WPBs is complex, with both initial formation and subse-
quent pre-exocytic stages of WPB biogenesis offering
opportunities to adjust this ratio [24], it is currently diffi-
cult to determine why a fall in protein is not observed.
The simplest explanation for the effects of GRK2
depletion on unregulated VWF secretion is a general fail-
ure in GPCR desensitization. The observed difference in
VWF release between GRK2-depleted cells assayed in
serum-free and reduced-serum media does suggest that
unidentified extracellular agonists may play such a role.
Unregulated secretion is, however, still enhanced by 30%
in the absence of serum. This could result from autocrine
or paracrine signaling; HUVEC confluency is known to
affect WPB numbers [59]. Alternatively, the recent obser-
vation that GRK2 depletion increases mitochondrial pro-
duction of ROS [16], known stimulants of WPB
exocytosis [60], may promote low-level endothelial-auton-
omous stimulation of WPB exocytosis.
Reduced organelle number had no inhibitory effect on
histamine-evoked VWF secretion. On the basis that, at
most, only 25% of total intracellular VWF was released
from GRK2-deficient cells upon histamine stimulation,
we suggest that organelle numbers are not limiting under
these conditions. Whether WPB number is relevant under
conditions such as chronic stimulation, remains to be
determined. Moreover, in vivo, endothelial cells are unli-
kely to be confronted by a single stimulus following
injury or infection. Angiotensin, vasopressin and adrena-
line all bind to receptors that are under GRK2 regulation
[61–63] and capable of stimulating WPB exocytosis [64–
66]. Indeed, VWF release is also enhanced in response to
adrenaline in GRK-depleted HUVECs (data not shown).
It may be that the combined activities of these secreta-
gogues, enhanced by the absence of receptor desensitiza-
tion, would exhaust WPBs in GRK-depleted cells quicker
than in control cells.
In conclusion, our data are consistent with a model in
which GRK2 limits endothelial activation at steady-state
and during an inflammatory response by desensitizing
GPCRs, including the histamine receptor, to the presence
of agonist. Together with previously published data, this
suggests that GRK2 activity could be required in both
endothelial cells and leukocytes to limit excess cellular
infiltration of inflamed tissues. The ability to modulate an
inflammatory response in at least two of the cell types
involved potentially allows for GRK2 to mount a coordi-
nated control of this finely balanced process.
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